The combination two-tablet oral drug therapy is likely to be recommended in India for use in patients with mild to moderate Covid, who are at risk of developing severe illness, a Union health ministry official stated
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/TkupmdE
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» New oral antiviral drug likely to get Centre's approval for treating Covid
https://ift.tt/BgiwDGj
No comments:
Post a Comment